Oxford vaccine moves towards pivotal trial against deadly Bundibugyo Ebola virus
· digitaljournal.com · popularity 20/100 · 0 similar stories today · Medicine & Clinical Health (Health & Life Sciences)
Read the original at digitaljournal.com →
Summary
An experimental vaccine developed at Oxford is set to move into a pivotal Phase 2/3 study in the Democratic Republic of the Congo, potentially bringing scientists closer to the first vaccine specifically approved against Bundibugyo virus. The post Oxford vaccine moves towards pivotal trial against deadly Bundibugyo Ebola virus appeared first on Digital Journal .
Found in: Digital Journal. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 6.